메뉴 건너뛰기




Volumn 10, Issue 4, 2011, Pages 282-287

Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma

Author keywords

Azelaic acid; Hydroquinone; Melasma

Indexed keywords

AZELAIC ACID; HYDROQUINONE; SUNSCREEN;

EID: 83255170491     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2011.00580.x     Document Type: Article
Times cited : (58)

References (24)
  • 1
  • 2
    • 33751349432 scopus 로고    scopus 로고
    • Guidelines for clinical trials in melasma. Pigmentation Disorders Academy
    • Pandya A, Berneburg M, Ortonne JP et al. Guidelines for clinical trials in melasma. Pigmentation Disorders Academy. Br J Dermatol 2006; 156(Suppl. 1): 21-8.
    • (2006) Br J Dermatol , vol.156 , Issue.SUPPL. 1 , pp. 21-28
    • Pandya, A.1    Berneburg, M.2    Ortonne, J.P.3
  • 4
    • 0036690396 scopus 로고    scopus 로고
    • Therapeutic effect of topical application of linoleic acid and lincomycin in combination with betamethasone valerate in melasma patients
    • Lee MH, Kim HJ, Ha DJ et al. Therapeutic effect of topical application of linoleic acid and lincomycin in combination with betamethasone valerate in melasma patients. J Korean Med Sci 2002; 17: 518-23.
    • (2002) J Korean Med Sci , vol.17 , pp. 518-523
    • Lee, M.H.1    Kim, H.J.2    Ha, D.J.3
  • 6
    • 39049190727 scopus 로고    scopus 로고
    • Topical treatments for melasma and postinflammatory hyperpigmentation
    • Lynde CB, Kraft JN, Lynde CW. Topical treatments for melasma and postinflammatory hyperpigmentation. Skin Therapy Lett 2006; 11: 1-6.
    • (2006) Skin Therapy Lett , vol.11 , pp. 1-6
    • Lynde, C.B.1    Kraft, J.N.2    Lynde, C.W.3
  • 7
    • 4444343580 scopus 로고    scopus 로고
    • A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma
    • Espinal-Perez LE, Moncada B, Castanedo-Cazares JP. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int J Dermatol 2004; 43: 604-7.
    • (2004) Int J Dermatol , vol.43 , pp. 604-607
    • Espinal-Perez, L.E.1    Moncada, B.2    Castanedo-Cazares, J.P.3
  • 8
    • 71949128374 scopus 로고    scopus 로고
    • Topical treatment of melasma
    • Bandyopadhyay D. Topical treatment of melasma. Indian J Dermatol 2009; 54: 303-9.
    • (2009) Indian J Dermatol , vol.54 , pp. 303-309
    • Bandyopadhyay, D.1
  • 9
    • 0029887004 scopus 로고    scopus 로고
    • Common disorders of pigmentation: when are more than cosmetic cover-ups required?
    • Hacker SM. Common disorders of pigmentation: when are more than cosmetic cover-ups required? Postgrad Med 1996; 99: 177-86.
    • (1996) Postgrad Med , vol.99 , pp. 177-186
    • Hacker, S.M.1
  • 10
    • 33750835911 scopus 로고    scopus 로고
    • The treatment of melasma: a review of clinical trials
    • Gupta AK, Gover MD, Nouri K et al. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol 2006; 55: 1048-65.
    • (2006) J Am Acad Dermatol , vol.55 , pp. 1048-1065
    • Gupta, A.K.1    Gover, M.D.2    Nouri, K.3
  • 11
    • 0000446185 scopus 로고
    • The use of azelaic acid in hyperpigmentation
    • Nazzaro-Porro M. The use of azelaic acid in hyperpigmentation. Rev Contemp Pharmacother 1993; 4: 415-23.
    • (1993) Rev Contemp Pharmacother , vol.4 , pp. 415-423
    • Nazzaro-Porro, M.1
  • 12
    • 0026029609 scopus 로고
    • Mechanism of inhibition of melanogenesis by hydroquinone
    • Palumbo A, d'Ischia M, Misuraca G et al. Mechanism of inhibition of melanogenesis by hydroquinone. Biochim Biophys Acta 1991; 1073: 85-90.
    • (1991) Biochim Biophys Acta , pp. 85-90
    • Palumbo, A.1    d'Ischia, M.2    Misuraca, G.3
  • 13
    • 0031760825 scopus 로고    scopus 로고
    • Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone
    • Kakita LS, Lowe NJ. Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone. Clin Ther 1998; 20: 960-70.
    • (1998) Clin Ther , vol.20 , pp. 960-970
    • Kakita, L.S.1    Lowe, N.J.2
  • 14
    • 0028357620 scopus 로고
    • Exogenous ochronosis with allergic contact dermatitis from hydroquinone
    • Camarasa JG, Serra-Baldrich E. Exogenous ochronosis with allergic contact dermatitis from hydroquinone. Contact Dermatitis 1994; 31: 57-8.
    • (1994) Contact Dermatitis , vol.31 , pp. 57-58
    • Camarasa, J.G.1    Serra-Baldrich, E.2
  • 15
    • 0025755308 scopus 로고
    • Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders
    • Fitton A, Goa KL. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 1991; 41: 780-98.
    • (1991) Drugs , vol.41 , pp. 780-798
    • Fitton, A.1    Goa, K.L.2
  • 16
    • 12244280178 scopus 로고
    • Azelaic acid in clinical medicine: an historical overview
    • Breathnach AS. Azelaic acid in clinical medicine: an historical overview. Rev Contemp Pharmacother 1993; 4: 395-401.
    • (1993) Rev Contemp Pharmacother , vol.4 , pp. 395-401
    • Breathnach, A.S.1
  • 17
    • 78650304993 scopus 로고    scopus 로고
    • Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method
    • Pandya AG, Hynan LS, Bhore R et al. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol 2011; 64: 78-83.
    • (2011) J Am Acad Dermatol , vol.64 , pp. 78-83
    • Pandya, A.G.1    Hynan, L.S.2    Bhore, R.3
  • 18
    • 0028334306 scopus 로고
    • Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial
    • Kimbrough-Green CK, Griffiths CE, Finkel LJ et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol 1994; 130: 727-33.
    • (1994) Arch Dermatol , vol.130 , pp. 727-733
    • Kimbrough-Green, C.K.1    Griffiths, C.E.2    Finkel, L.J.3
  • 19
    • 0026094111 scopus 로고
    • N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma
    • Jimbow K. N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma. Arch Dermatol 1991; 127: 1528-34.
    • (1991) Arch Dermatol , vol.127 , pp. 1528-1534
    • Jimbow, K.1
  • 21
    • 33845744356 scopus 로고    scopus 로고
    • Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma
    • Erbil H, Sezer E, Tastan B et al. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma. J Dermatol 2007; 34: 25-30.
    • (2007) J Dermatol , vol.34 , pp. 25-30
    • Erbil, H.1    Sezer, E.2    Tastan, B.3
  • 22
    • 0024354533 scopus 로고
    • Azelaic acid: mode of action at cellular and subcellular levels
    • Galhaup I. Azelaic acid: mode of action at cellular and subcellular levels. Acta Derm Venereol Suppl (Stockh) 1989; 143: 75-82.
    • (1989) Acta Derm Venereol Suppl (Stockh) , vol.143 , pp. 75-82
    • Galhaup, I.1
  • 23
    • 0024310481 scopus 로고
    • Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma
    • Verallo-Rowell VM, Verallo V, Graupe K et al. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol Suppl (Stockh) 1989; 143: 58-61.
    • (1989) Acta Derm Venereol Suppl (Stockh) , vol.143 , pp. 58-61
    • Verallo-Rowell, V.M.1    Verallo, V.2    Graupe, K.3
  • 24
    • 0025833794 scopus 로고
    • The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream
    • Balina LM, Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 1991; 30: 893-5.
    • (1991) Int J Dermatol , vol.30 , pp. 893-895
    • Balina, L.M.1    Graupe, K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.